Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition
9 May 2026 – 14 May 2026
· Cape Town, South Africa
663-01-007
ISMRM Abstract
3.0T MOLLI-based T1 Mapping Without Iron Correction for Assessment of Hepatic Inflammation and Fibrosis in MASLD
Primary:
Analysis Methods - Data Processing
Secondary:
Analysis Methods - Radiomics
663-01-007 · Diffusion MRI, Iron Quantification, and Steatosis in Human and Preclinical Studies
· Thursday, 14 May, 8:30 AM–9:25 AM · Digital Posters Row D
1Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, China
2Shanghai United Imaging Healthcare Co., Ltd, Shanghai, China
Presenting Author: Yujin Chu
Synopsis
Motivation:
Goals:
Approach:
Results:
Full abstract & presentation
The full text, figures, and any recorded presentation for this abstract are not shown here. Log in if you are a member or registered attendee with access.
Full abstracts, figures, and presentations for Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition are available to registered attendees. This content becomes freely available to the public roughly two years after the meeting.
To request or purchase access, contact the ISMRM Central Office at info@ismrm.org.
1. 1. Banerjee R, Pavlides M, Tunnicliffe EM, Piechnik SK, Sarania N, Philips R, Collier JD, Booth JC, Schneider JE, Wang LM, Delaney DW, Fleming KA, Robson MD, Barnes E, Neubauer S. Multiparametric magnetic resonance for the non-invasive diagnosis of liver disease. J Hepatol. 2014 Jan;60(1):69-77. doi: 10.1016/j.jhep.2013.09.002. Epub 2013 Sep 12. PMID: 24036007; PMCID: PMC3865797. [doi][pmid]
2. 2. Pavlides M, Banerjee R, Tunnicliffe EM, Kelly C, Collier J, Wang LM, Fleming KA, Cobbold JF, Robson MD, Neubauer S, Barnes E. Multiparametric magnetic resonance imaging for the assessment of non-alcoholic fatty liver disease severity. Liver Int. 2017 Jul;37(7):1065-1073. doi: 10.1111/liv.13284. Epub 2017 May 30. PMID: 27778429; PMCID: PMC5518289. [doi][pmid]
3. 3. Eddowes PJ, Sasso M, Allison M, Tsochatzis E, Anstee QM, Sheridan D, Guha IN, Cobbold JF, Deeks JJ, Paradis V, Bedossa P, Newsome PN. Accuracy of FibroScan Controlled Attenuation Parameter and Liver Stiffness Measurement in Assessing Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease. Gastroenterology. 2019 May;156(6):1717-1730. doi: 10.1053/j.gastro.2019.01.042. Epub 2019 Jan 25. PMID: 30689971. [doi][pmid]
4. 4. Ahn JH, Yu JS, Park KS, Kang SH, Huh JH, Chang JS, Lee JH, Kim MY, Nickel MD, Kannengiesser S, Kim JY, Koh SB. Effect of hepatic steatosis on native T1 mapping of 3T magnetic resonance imaging in the assessment of T1 values for patients with non-alcoholic fatty liver disease. Magn Reson Imaging. 2021 Jul;80:1-8. doi: 10.1016/j.mri.2021.03.015. Epub 2021 Mar 30. PMID: 33798658. [doi][pmid]